Unisol 25 mg/ml oral solution for calves

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
28-02-2023
공공 평가 보고서 공공 평가 보고서 (PAR)
03-07-2019
DSU DSU (DSU)
28-02-2023

유효 성분:

Enrofloxacin

제공처:

Vetpharma Animal Health, S.L.

ATC 코드:

QJ01MA90

INN (International Name):

Enrofloxacin

복용량:

25 milligram(s)/millilitre

약제 형태:

Oral solution

처방전 유형:

POM: Prescription Only Medicine as defined in relevant national legislation

치료 그룹:

Cattle

치료 영역:

enrofloxacin

치료 징후:

Antibacterial

승인 상태:

Authorised

승인 날짜:

2009-07-10

제품 특성 요약

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Unisol 25 mg/ml oral solution for calves [IE, IT]
UNISOL 25 mg/ml oral solution for calves [ES]
DORAFLOX 25 mg/ml oral solution for calves [BE]
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Enrofloxacin ..................................... 25.0
mg
EXCIPIENTS:
Qualitative composition of
excipients and other
constituents
Quantitative composition if that
information is essential for proper
administration of the veterinary medicinal
product
Benzyl Alcohol (E 1519)
14.0 mg
Potassium hydroxide
--
Hypromellose
--
Purified water
--
Aqueous, clear solution.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Cattle (Pre-ruminant calves).
3.2.
INDICATIONS FOR USE FOR EACH TARGET SPECIES
In calves:
-
treatment of respiratory infections due to _ Pasteurella multocida_
and
_Mannheimia haemolytica._
-
treatment of gastro-intestinal infection due to _Escherichia coli_.
To be used where clinical experience and/or sensitivity testing
indicates
enrofloxacin as the drug of choice.
3.3.
CONTRAINDICATIONS
Do not use when resistance / cross-resistance to (fluoro)quinolones is
known to occur in the flock intended for treatment.
Do not use in cases of hypersensitivity to the active substance, other
(fluoro)quinolones or to any of the excipients.
Do not use in case of disturbances in growth of cartilage and/or
during
injury of locomotory system particularly on functionally loaded joints
or due
to body weight loaded joints.
3.4
SPECIAL WARNINGS
None.
3.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for safe use in the target species:
Do not use for prophylaxis.
During the period of rapid growth, enrofloxacin may affect articular
cartilage.
Official and local antimicrobial policies should be taken into account
when
the product is used.
Fluoroquinolones
should
be
reserved
for
the
treatment
of
clinical
conditions which have responded poorly, or are expected to respond
poorly, to other classes of antimicrobials.
Wherever possible, fluor
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림